Media
Latest News
Washington, D.C. – Tonight, following President Trump’s State of the Union Address, Congressman Michael Guest (MS-03) issued the following statement.
CLICK HERE to watch/download speech
Washington, D.C. – Today, Congressman Michael Guest (MS-03) highlighted the importance of improving security measures for nonprofits, 501(c)(3) organizations including houses of worship, and supported steps taken by the Administration to advance prevention of violent acts targeting faith-based institutions.
Today, U.S. Reps. Angie Craig (MN-02), Pete Stauber (MN-08), Dean Phillips (MN-03) and Michael Guest (MS-03) introduced bipartisan legislation to require an examination of the health and economic impacts of skyrocketing insulin prices.
Brandon, Mississippi – Congressman Guest (MS-03) is pleased to announce that Chad Bynum, eighth-grade student at Brandon Middle School, was selected by a panel of professionals in the technology industry and Congressional App Challenge organization staff as the winner of the 2019 Congressional App Challenge for the Third Congressional District.
Washington, D.C. – Congressman Michael Guest (MS-03) joined other lawmakers in praising the signing of the Economic and Trade Agreement Between the United States of America and the People’s Republic of China, a long-awaited trade agreement that addresses China’s history of currency manipulation, intellectual property theft, and trade balance with the U.S.
CLICK HERE to watch or download floor speech on American strikes against Iran
Washington, DC – This morning, Congressman Michael Guest (MS-03) released a statement in response to the news that the Defense Department had conducted an airstrike at the direction of President Donald Trump on Baghdad International Airport to kill the leader of Iran’s Quds Force, General Qassem Soleimani.
Washington, DC – Today, Congressman Michael Guest (MS-03) voted against H.R. 3 – the Lower Drug Costs Now Act of 2019. Congressman Guest’s primary concern was the likelihood that the bill would result in the creation of fewer cures and hinder the development of new drugs to treat illnesses.